Ceribell, Inc. (CBLL) income statement
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.63−0.34 (-1.31%)
Close on Nov 18, 2026Market cap $983.63MP/E –Yield –
Ceribell, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 88.9%
- Operating margin
- -68.6%
- Net margin
- -64.7%
- Return on equity, FY2025
- -30.8%
Financial strength
- Current ratio
- 9.18
- Debt to equity
- 0.16
- Debt to assets
- 12.0%
- Cash to current liabilities
- 189.9%
Valuation
- P/E ratio
- –
- Price to sales
- 9.65
- Price to book
- 7.67
- Dividend yield
- –
See a number that looks wrong?